Global Guideline for Type 2 Diabetes
| Autor: | International Diabetes Federation Guideline Development Group, The, Aschner, P., Beck-Nielsen, H., Bennett, P., Boulton, A., Colagiuri, R., Colagiuri, S., Franz, M., Gadsby, R., Gagliardino, J.J., Home, P., McGill, M., Manley, S., Marshall, S., Mbanya, J.C., Neil, A., Ramachandran, A., Ramaiya, K., Roglic, G., Schaper, N., Siminerio, L., Sinclair, A., Snoek, F., van Crombrugge, P., Vespasiani, G., Viswanathan, V., Sim, K. |
|---|---|
| Přispěvatelé: | Medical Psychology, Interne Geneeskunde, RS: CAPHRI School for Public Health and Primary Care, RS: CAPHRI - Redesigning Health Care, Medical psychology, EMGO - Lifestyle, overweight and diabetes |
| Jazyk: | angličtina |
| Rok vydání: | 2014 |
| Předmět: |
Gerontology
medicine.medical_specialty CIENCIAS MÉDICAS Y DE LA SALUD Cost effectiveness Endocrinology Diabetes and Metabolism Type 2 diabetes Medicina Clínica Guidelines MICROVASCULAR COMPLICATIONS Global Health COST-EFFECTIVENESS Endocrinology Diabetes mellitus Endocrinología y Metabolismo GLYCEMIC CONTROL Internal Medicine medicine Belgica CARDIOVASCULAR RISK-FACTORS Quality of Care Humans Guideline development CORONARY-HEART-DISEASE International diabetes federation Developing Countries Glycated Hemoglobin biology business.industry Developed Countries Diabetes SELF-MANAGEMENT EDUCATION Disease Management International Agencies INTENSIVE INSULIN THERAPY BLOOD-GLUCOSE General Medicine Guideline medicine.disease biology.organism_classification Coronary heart disease Diabetes Mellitus Type 2 MYOCARDIAL-INFARCTION Cardiovascular Diseases Family medicine business PRIMARY PREVENTION |
| Zdroj: | Diabetes research and clinical practice, 104(1), 1-52. Elsevier Ireland Ltd Snoek, F J 2014, ' Global guideline for type 2 diabetes ', Diabetes Research and Clinical Practice, vol. 104, no. 1, pp. 1-52 . https://doi.org/10.1016/j.diabres.2012.10.001 Diabetes Research and Clinical Practice, 104(1), 1-52. Elsevier Ireland Ltd |
| ISSN: | 0168-8227 |
| DOI: | 10.1016/j.diabres.2012.10.001 |
| Popis: | There is now extensive evidence on the optimal management of diabetes, offering the opportunity of improving the immediate and long-term quality of life of those with diabetes. Unfortunately such optimal management is not reaching many, perhaps the majority, of the people who could benefi t. Reasons include the size and complexity of the evidencebase, and the complexity of diabetes care itself. One result is a lack of proven cost-effective resources for diabetes care. Another result is diversity of standards of clinical practice. Guidelines are one part of a process which seeks to address those problems. Many guidelines have appeared internationally, nationally, and more locally in recent years, but most of these have not used the rigorous new guideline methodologies for identifi cation and analysis of the evidence. Many countries around the world do not have the resources, either in expertise or fi nancially, that are needed to develop diabetes guidelines. Also such a repetitive approach would be enormously ineffi cient and costly. Published national guidelines come from relatively resource-rich countries, and may be of limited practical use in less well resourced countries. In 2005 the fi rst IDF Global Guideline for type 2 diabetes was developed. This presented a unique challenge as we tried to develop a guideline that is sensitive to resource and costeffectiveness issues. Many national guidelines address one group of people with diabetes in the context of one healthcare system, with one level of national and health-care resources. This is not true in the global context where, although every health-care system seems to be short of resources, the funding and expertise available for health-care vary widely between countries and even between localities. Despite the challenges, we feel that we found an approach which is at least partially successful in addressing this issue which we termed ‘Levels of care’ (see next page). This guideline represents an update of the fi rst guideline and extends the evidence base by including new studies and treatments which have emerged since the original guideline was produced in 2005. Funding is essential to an activity of this kind. IDF is grateful to a diversity of commercial partners for provision of unrestricted educational grants. Fil: Aschner, Pablo. International Diabetes Federation Guideline Development Group; Bélgica Fil: Beck Nielsen, Henning. International Diabetes Federation Guideline Development Group; Bélgica Fil: Bennet, Peter. International Diabetes Federation Guideline Development Group; Bélgica Fil: Boulton, Andrew. International Diabetes Federation Guideline Development Group; Bélgica Fil: Colagiuri, Ruth. International Diabetes Federation Guideline Development Group; Bélgica Fil: Colagiuri, Stephen. International Diabetes Federation Guideline Development Group; Bélgica Fil: Franz, Marion. International Diabetes Federation Guideline Development Group; Bélgica Fil: Gadsby, Roger. International Diabetes Federation Guideline Development Group; Bélgica Fil: Gagliardino, Juan Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Cientifico Tecnológico La Plata. Centro de Endocrinologia Experimental y Aplicada (i); Argentina. Universidad Nacional de La Plata; Argentina. International Diabetes Federation Guideline Development Group; Bélgica Fil: Home, Philip. International Diabetes Federation Guideline Development Group; Bélgica Fil: McGill, Marg. International Diabetes Federation Guideline Development Group; Bélgica Fil: Manley, Susan. International Diabetes Federation Guideline Development Group; Bélgica Fil: Marshall, Sally. International Diabetes Federation Guideline Development Group; Bélgica Fil: Mbanya, Jean Claude. International Diabetes Federation Guideline Development Group; Bélgica Fil: Neil, Andrew. International Diabetes Federation Guideline Development Group; Bélgica Fil: Ramachandran, Ambady. International Diabetes Federation Guideline Development Group; Bélgica Fil: Ramaiya, Kaushik. International Diabetes Federation Guideline Development Group; Bélgica Fil: Roglic, Gojka. International Diabetes Federation Guideline Development Group; Bélgica Fil: Schaper, Nicolaas. International Diabetes Federation Guideline Development Group; Bélgica Fil: Siminerio, Linda. International Diabetes Federation Guideline Development Group; Bélgica Fil: Sinclair, Alan. International Diabetes Federation Guideline Development Group; Bélgica Fil: Snoek, Frank. International Diabetes Federation Guideline Development Group; Bélgica Fil: Van Crombrugge, Paul. International Diabetes Federation Guideline Development Group; Bélgica Fil: Vespasiani, Giacomo. International Diabetes Federation Guideline Development Group; Bélgica Fil: Viswanathan, Vijay . International Diabetes Federation Guideline Development Group; Bélgica |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect